Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about financial results

Recent news which mentions financial results

< Previous 1 2 3 4 5 6 Next >
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
Tickers IWINF
Tags financial results News premium
From Benzinga
This Canadian Co. Said Farewell To Cannabis, Stock Surges On Heels Of Q1 Earnings Report
Tickers NEPT
Tags premium first quarter earnings report Penny Stocks
From Benzinga
Canadian Cannabis Producer Reports YoY Revenue Spike In Q2, Earnings Show Stable Growth As Demand Grows
Tickers DBCCF
Tags Earnings Penny Stocks premium
From Benzinga
Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
Tickers EVGN
Tags Government EVGN Benzinga
From Benzinga
This Cannabis MSO's Q2 Results Reflect Healthy Momentum Amid Industry Headwinds
Tickers AYRWF
Tags Government David Goubert Benzinga
From Benzinga
$21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO's Q2 2023
Tickers SCTL
Tags SCTL Management Psychedelic Drug Development
From Benzinga
Cresco Labs Reports Slight Sequential Improvement In Q2, YoY Drop In Revenue And Gross Profit As Net Loss Grows
Tickers CCHWF CRLBF
Tags Small Cap CRLBF Benzinga
From Benzinga
Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
Tickers FLHLF JAQC
Tags Market News Cannabis Markets
From Benzinga
Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs
Tickers MYCOF
Tags MYCOF News financial results
From Benzinga
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
Tickers AVCNF
Tags News financial results Earnings
From Benzinga
Cybin's Q1 2023 Financials, Deuterated Psychedelics Moving 'Steadily' Through The Clinic
Tickers CYBN
Tags Financing CYBN Psychedelic Therapy
From Benzinga
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
Tickers ENVB
Tags Global Next/Generation Psychedelics ENVB
From Benzinga
Cannabis Real Estate Firm's Q2 Earnings Results Signal Steady Growth, Here's What You Need To Know
Tickers ZDPY
Tags Benzinga Earnings Penny Stocks
From Benzinga
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
Tickers IMCC
Tags News financial results Earnings
From Benzinga
Columbia Care: Q2 Report Reveals Profits In East Coast Market But This Was Before Failed Sean Diddy Mega Merger
Tickers CCHWF CRLBF
Tags financial results Nicholas Vita News
From Benzinga
Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA
Tickers ATAI CMPS
Tags Cannabis Market News Markets
From Benzinga
MindMed's Q2 2023: One Of Biggest Players In The Space Sustains Faith In LSD's Multiple Path Ahead
Tickers MNMD
Tags Financing Management psychedelic/assisted therapy
From Benzinga
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'
Tickers CMPS HTGC
Tags Psilocybin program Psychedelics Benzinga
From Benzinga
Increased Production & Retail Sales For Magic Truffles: Red Light Holland Balances 2023 Financial Results
Tickers TRUFF
Tags Psychedelic/Assisted Therapies Psychedelics Benzinga
From Benzinga
Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
Tickers ATAI CMPS DMTTF DRUG
Tags Small Cap Financing DRUG
From Benzinga
Positive Cash Flow Marks Significant Milestone For This Multi-State Cannabis Operator
Tickers AAWH
Tags earning reports Benzinga Ascend Wellness Holdings Inc/
From Benzinga
Jack In The Box Partnership Helps Weedmaps Report Positive Q1 Earnings Despite Revenue Decrease
Tickers MAPS
Tags Benzinga Management MAPS
From Benzinga
Hydroponic Retailer GrowGeneration Posts $56.8M In Q1 2023 Revenue
Tickers GRWG
Tags financial results hydroponics News
From Benzinga
Numinus Q2 2023: 581% Revenue Growth, 820% In Gross Profit And Strong Cash Position
Tickers NUMIF
Tags Cedar Clinical Research Psychedelics Benzinga
From Benzinga
Mydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And More
Tickers MYCOF
Tags Psychedelics Benzinga Cannabis
From Benzinga
Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
Tickers FLHLF JAGX
Tags Psilocybin program Benzinga Psychedelics
From Benzinga
Atai Life Sciences Hopes Hercules Can Help 'Sustain' Operations Until 2026
Tickers ATAI CMPS
Tags Cannabis Market News Markets
From Benzinga
MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies
Tickers MNMD
Tags University Hospital Basel Psychedelic/Assisted Therapies Benzinga
From Benzinga
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
Tickers BRAXF IWINF
Tags Markets Cannabis Market News
From Benzinga
Field Trip H&W Closes Q3 2023 On Material Uncertainty, Need To Lower Costs & Adapt To New Regulations
Tickers FTHWF
Tags Penny Stocks Earnings financial results
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.